| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | galactosidase activity | 4.46e-06 | 7 | 102 | 3 | GO:0015925 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.93e-05 | 81 | 102 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 9.66e-05 | 144 | 102 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 9.67e-05 | 47 | 102 | 4 | GO:0016790 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP6V0B SLC5A7 SLC13A3 NDUFA9 SLC18B1 SLC6A9 SLC13A1 SLC29A1 | 1.56e-04 | 301 | 102 | 8 | GO:0022853 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.86e-04 | 103 | 102 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.91e-04 | 310 | 102 | 8 | GO:0030246 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 2.56e-04 | 5 | 102 | 2 | GO:0004565 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 3.46e-04 | 27 | 102 | 3 | GO:0047617 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.63e-04 | 119 | 102 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 3.86e-04 | 28 | 102 | 3 | GO:0016289 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 5.24e-04 | 31 | 102 | 3 | GO:0030247 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V0B SLC5A7 SLC13A3 NDUFA9 SLC18B1 ABCA7 SLC6A9 SLC13A1 SLC29A1 | 7.55e-04 | 477 | 102 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 8.66e-04 | 83 | 102 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | symporter activity | 1.04e-03 | 150 | 102 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP6V0B SLC5A7 SLC13A3 AQP8 STING1 NDUFA9 SLC18B1 SLC6A9 SLC13A1 SLC29A1 | 1.38e-03 | 627 | 102 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP6V0B SLC5A7 SLC13A3 AQP8 STING1 NDUFA9 SLC18B1 AQP6 SLC6A9 SLC13A1 SLC29A1 | 1.69e-03 | 758 | 102 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.85e-03 | 171 | 102 | 5 | GO:0015081 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glycinergic | 2.52e-05 | 2 | 104 | 2 | GO:0060092 | |
| GeneOntologyBiologicalProcess | saturated monocarboxylic acid metabolic process | 2.52e-05 | 2 | 104 | 2 | GO:0032788 | |
| GeneOntologyBiologicalProcess | unsaturated monocarboxylic acid metabolic process | 2.52e-05 | 2 | 104 | 2 | GO:0032789 | |
| GeneOntologyBiologicalProcess | quinone biosynthetic process | 8.04e-05 | 17 | 104 | 3 | GO:1901663 | |
| GeneOntologyBiologicalProcess | ubiquinone biosynthetic process | 8.04e-05 | 17 | 104 | 3 | GO:0006744 | |
| GeneOntologyBiologicalProcess | organic cation transport | 9.38e-05 | 145 | 104 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | ubiquinone metabolic process | 1.33e-04 | 20 | 104 | 3 | GO:0006743 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 1.37e-04 | 52 | 104 | 4 | GO:0001504 | |
| GeneOntologyCellularComponent | lysosomal lumen | 1.36e-04 | 98 | 105 | 5 | GO:0043202 | |
| GeneOntologyCellularComponent | microbody | 1.69e-04 | 162 | 105 | 6 | GO:0042579 | |
| GeneOntologyCellularComponent | peroxisome | 1.69e-04 | 162 | 105 | 6 | GO:0005777 | |
| GeneOntologyCellularComponent | secretory vesicle | ANPEP FSTL4 SLC5A7 STING1 HUWE1 SLC18B1 PHAF1 SLC6A9 SERPINA1 GLA GUSB CD33 AGL SMPD1 PCSK4 NOS1 | 4.75e-04 | 1246 | 105 | 16 | GO:0099503 |
| GeneOntologyCellularComponent | multivesicular body lumen | 5.16e-04 | 7 | 105 | 2 | GO:0097486 | |
| GeneOntologyCellularComponent | secretory granule | ANPEP FSTL4 STING1 HUWE1 SLC18B1 SLC6A9 SERPINA1 GLA GUSB CD33 AGL SMPD1 PCSK4 NOS1 | 5.46e-04 | 1014 | 105 | 14 | GO:0030141 |
| GeneOntologyCellularComponent | endosome lumen | 1.31e-03 | 43 | 105 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | late endosome lumen | 1.33e-03 | 11 | 105 | 2 | GO:0031906 | |
| Domain | BAAT_C | 1.57e-06 | 5 | 102 | 3 | IPR014940 | |
| Domain | BAAT_C | 1.57e-06 | 5 | 102 | 3 | PF08840 | |
| Domain | - | 2.90e-06 | 73 | 102 | 6 | 2.60.120.260 | |
| Domain | Glycoside_hydrolase_SF | 1.03e-05 | 53 | 102 | 5 | IPR017853 | |
| Domain | Galactose-bd-like | 1.26e-05 | 94 | 102 | 6 | IPR008979 | |
| Domain | - | 3.85e-05 | 35 | 102 | 4 | 3.20.20.80 | |
| Domain | Glyco_hydro_catalytic_dom | 5.37e-05 | 38 | 102 | 4 | IPR013781 | |
| Domain | C-type_lectin_CS | 8.78e-05 | 43 | 102 | 4 | IPR018378 | |
| Domain | Glyco_hydro_35 | 1.76e-04 | 4 | 102 | 2 | PF01301 | |
| Domain | Gly_Hdrlase_35_cat | 1.76e-04 | 4 | 102 | 2 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 1.76e-04 | 4 | 102 | 2 | IPR001944 | |
| Domain | Bile_Hydr_Trans | 1.76e-04 | 4 | 102 | 2 | PF04775 | |
| Domain | B-gal_1-like | 1.76e-04 | 4 | 102 | 2 | IPR026283 | |
| Domain | GLYCOSYL_HYDROL_F35 | 1.76e-04 | 4 | 102 | 2 | PS01182 | |
| Domain | Thio_Ohase/aa_AcTrfase | 1.76e-04 | 4 | 102 | 2 | IPR006862 | |
| Domain | Acyl-CoA_thioEstase_long-chain | 1.76e-04 | 4 | 102 | 2 | IPR016662 | |
| Domain | Na/sul_symport | 2.92e-04 | 5 | 102 | 2 | IPR001898 | |
| Domain | Na_sulph_symp | 2.92e-04 | 5 | 102 | 2 | PF00939 | |
| Domain | PrprotnconvertsP | 6.09e-04 | 7 | 102 | 2 | IPR002884 | |
| Domain | Aspartic_peptidase_N | 6.09e-04 | 7 | 102 | 2 | IPR012848 | |
| Domain | P_proprotein | 6.09e-04 | 7 | 102 | 2 | PF01483 | |
| Domain | S8_pro-domain | 6.09e-04 | 7 | 102 | 2 | IPR032815 | |
| Domain | - | 6.09e-04 | 7 | 102 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 6.09e-04 | 7 | 102 | 2 | PF16470 | |
| Domain | A1_Propeptide | 6.09e-04 | 7 | 102 | 2 | PF07966 | |
| Domain | C_TYPE_LECTIN_1 | 9.65e-04 | 80 | 102 | 4 | PS00615 | |
| Domain | Peptidase_S8_His-AS | 1.04e-03 | 9 | 102 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 1.04e-03 | 9 | 102 | 2 | IPR023828 | |
| Domain | Lectin_C | 1.16e-03 | 84 | 102 | 4 | PF00059 | |
| Domain | CLECT | 1.16e-03 | 84 | 102 | 4 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 1.21e-03 | 85 | 102 | 4 | PS50041 | |
| Domain | C-type_lectin-like | 1.26e-03 | 86 | 102 | 4 | IPR001304 | |
| Domain | Aspartic_peptidase_A1 | 1.29e-03 | 10 | 102 | 2 | IPR001461 | |
| Domain | Peptidase_S8_subtilisin-rel | 1.29e-03 | 10 | 102 | 2 | IPR015500 | |
| Domain | PEPTIDASE_A1 | 1.29e-03 | 10 | 102 | 2 | IPR033121 | |
| Domain | MIP_CS | 1.29e-03 | 10 | 102 | 2 | IPR022357 | |
| Domain | Asp | 1.29e-03 | 10 | 102 | 2 | PF00026 | |
| Domain | PEPTIDASE_A1 | 1.29e-03 | 10 | 102 | 2 | PS51767 | |
| Domain | SUBTILASE_ASP | 1.29e-03 | 10 | 102 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 1.29e-03 | 10 | 102 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 1.29e-03 | 10 | 102 | 2 | PS00138 | |
| Domain | - | 1.57e-03 | 11 | 102 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 1.57e-03 | 11 | 102 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 1.57e-03 | 11 | 102 | 2 | PF00082 | |
| Domain | - | 1.88e-03 | 12 | 102 | 2 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 1.88e-03 | 12 | 102 | 2 | PS00141 | |
| Domain | - | 1.97e-03 | 97 | 102 | 4 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 2.12e-03 | 99 | 102 | 4 | IPR016186 | |
| Domain | Aspartic_peptidase_AS | 2.22e-03 | 13 | 102 | 2 | IPR001969 | |
| Domain | - | 2.57e-03 | 50 | 102 | 3 | 2.60.120.40 | |
| Domain | MIP | 2.57e-03 | 14 | 102 | 2 | PS00221 | |
| Domain | MIP | 2.57e-03 | 14 | 102 | 2 | PF00230 | |
| Domain | CTDL_fold | 2.81e-03 | 107 | 102 | 4 | IPR016187 | |
| Domain | MIP | 2.96e-03 | 15 | 102 | 2 | IPR000425 | |
| Domain | - | 2.96e-03 | 15 | 102 | 2 | 1.20.1080.10 | |
| Domain | - | 2.96e-03 | 15 | 102 | 2 | 3.40.33.10 | |
| Domain | CAP | 2.96e-03 | 15 | 102 | 2 | PF00188 | |
| Domain | CAP_domain | 2.96e-03 | 15 | 102 | 2 | IPR014044 | |
| Domain | SCP | 2.96e-03 | 15 | 102 | 2 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 2.96e-03 | 15 | 102 | 2 | IPR001283 | |
| Domain | Aquaporin-like | 2.96e-03 | 15 | 102 | 2 | IPR023271 | |
| Domain | Propept_inh | 3.81e-03 | 17 | 102 | 2 | IPR009020 | |
| Domain | Peptidase_aspartic_dom | 3.81e-03 | 17 | 102 | 2 | IPR021109 | |
| Domain | ig | 3.88e-03 | 190 | 102 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.88e-03 | 190 | 102 | 5 | IPR013151 | |
| Domain | Tumour_necrosis_fac-like_dom | 3.92e-03 | 58 | 102 | 3 | IPR008983 | |
| Domain | Furin_repeat | 4.27e-03 | 18 | 102 | 2 | IPR006212 | |
| Domain | FU | 4.27e-03 | 18 | 102 | 2 | SM00261 | |
| Pathway | WP_7OXOC_AND_7BETAHC_PATHWAYS | 1.61e-05 | 27 | 81 | 4 | M40054 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 4.11e-05 | 34 | 81 | 4 | MM17076 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | GLB1L3 AMACR FA2H ACOT1 ACOT6 GLB1L2 LBR ACOT4 PTGIS LHB GLA SMPD1 PIK3R5 | 4.85e-05 | 620 | 81 | 13 | MM15193 |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 7.14e-05 | 39 | 81 | 4 | M48042 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 1.84e-04 | 92 | 81 | 5 | MM15086 | |
| Pathway | WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL | 2.06e-04 | 51 | 81 | 4 | M39754 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 2.39e-04 | 53 | 81 | 4 | MM14647 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V0B SLC5A7 SLC13A3 APOB AQP8 AQP6 ABCA7 SLC6A9 SLC13A1 SCARB1 DERL3 SLC7A10 SLC29A1 | 2.69e-04 | 736 | 81 | 13 | M27287 |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 2.98e-04 | 23 | 81 | 3 | MM14804 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.17e-04 | 57 | 81 | 4 | M692 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 3.22e-04 | 5 | 81 | 2 | MM15099 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 3.22e-04 | 5 | 81 | 2 | M27354 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 3.39e-04 | 58 | 81 | 4 | M576 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 3.39e-04 | 24 | 81 | 3 | M636 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | GLB1L3 AMACR FA2H ACOT1 ACOT6 GLB1L2 LBR ACOT4 PTGIS LHB GLA SMPD1 PIK3R5 | 3.53e-04 | 757 | 81 | 13 | M27451 |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 3.72e-04 | 107 | 81 | 5 | M14857 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS | 4.82e-04 | 6 | 81 | 2 | M27220 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V0B SLC5A7 SLC13A3 APOB AQP8 ABCA7 SLC6A9 SLC13A1 SCARB1 DERL3 SLC7A10 SLC29A1 | 4.85e-04 | 681 | 81 | 12 | MM14985 |
| Pathway | REACTOME_PEROXISOMAL_LIPID_METABOLISM | 5.40e-04 | 28 | 81 | 3 | MM15010 | |
| Pathway | REACTOME_PEROXISOMAL_LIPID_METABOLISM | 6.00e-04 | 29 | 81 | 3 | M2286 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 6.63e-04 | 30 | 81 | 3 | M27566 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 7.85e-04 | 126 | 81 | 5 | M695 | |
| Pathway | WP_MONOAMINE_TRANSPORT | 8.04e-04 | 32 | 81 | 3 | M39724 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 9.48e-04 | 76 | 81 | 4 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.38e-03 | 84 | 81 | 4 | M27334 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 16940157 | ||
| Pubmed | A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. | 2.28e-06 | 9 | 106 | 3 | 16103133 | |
| Pubmed | Linkage mapping of 40 randomly isolated liver cDNA clones in the mouse. | 3.72e-06 | 76 | 106 | 5 | 8288233 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | PGA4 ANPEP GPRC5C APOB CPN2 CUTA SERPINA1 GLA HMCN1 GUSB ENTPD2 MMRN2 SMPD1 PGA3 | 4.77e-06 | 1070 | 106 | 14 | 23533145 |
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 8631881 | ||
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 7.57e-06 | 41 | 106 | 4 | 23676500 | |
| Pubmed | 7.70e-06 | 13 | 106 | 3 | 18245842 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19801629 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24991573 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 35123618 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37887344 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18586241 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12621451 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18794057 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16449193 | ||
| Pubmed | Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. | 9.20e-06 | 2 | 106 | 2 | 8227051 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12878320 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26779650 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37967646 | ||
| Pubmed | 1.45e-05 | 257 | 106 | 7 | 16335952 | ||
| Pubmed | 1.50e-05 | 16 | 106 | 3 | 8798769 | ||
| Pubmed | 2.57e-05 | 19 | 106 | 3 | 21052031 | ||
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 2.76e-05 | 3 | 106 | 2 | 26170455 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7926498 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9561228 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21455714 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19800305 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 2.76e-05 | 3 | 106 | 2 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 2.76e-05 | 3 | 106 | 2 | 2799289 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 2.76e-05 | 3 | 106 | 2 | 1968039 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8053437 | ||
| Pubmed | Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine. | 2.76e-05 | 3 | 106 | 2 | 35790189 | |
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 2.76e-05 | 3 | 106 | 2 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 2.76e-05 | 3 | 106 | 2 | 2229438 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 2.76e-05 | 3 | 106 | 2 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 2.76e-05 | 3 | 106 | 2 | 8244094 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21407214 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 6774973 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 2.76e-05 | 3 | 106 | 2 | 22304859 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24004680 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 2.76e-05 | 3 | 106 | 2 | 2227273 | |
| Pubmed | Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders. | 2.76e-05 | 3 | 106 | 2 | 20385825 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23034090 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24125879 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 2.76e-05 | 3 | 106 | 2 | 3554488 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23521833 | ||
| Pubmed | Clinical spectrum in multiple families with primary COQ10 deficiency. | 2.76e-05 | 3 | 106 | 2 | 33215859 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 2.76e-05 | 3 | 106 | 2 | 21989121 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9855083 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9797498 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 2478370 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 2.76e-05 | 3 | 106 | 2 | 10675278 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3780036 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10567408 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 2.76e-05 | 3 | 106 | 2 | 3839486 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3467902 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 2.76e-05 | 3 | 106 | 2 | 2892778 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24383519 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 2.76e-05 | 3 | 106 | 2 | 2831884 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12235173 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 2032552 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 1812762 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7923573 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 2.76e-05 | 3 | 106 | 2 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 2.76e-05 | 3 | 106 | 2 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 2.76e-05 | 3 | 106 | 2 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 2.76e-05 | 3 | 106 | 2 | 1956484 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8540382 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 2.76e-05 | 3 | 106 | 2 | 20981206 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16336259 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 2.76e-05 | 3 | 106 | 2 | 8504820 | |
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 2.76e-05 | 3 | 106 | 2 | 33603190 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 2.76e-05 | 3 | 106 | 2 | 21970995 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20428942 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9525001 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7886402 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17379991 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21547904 | ||
| Pubmed | Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. | 3.59e-05 | 121 | 106 | 5 | 8827514 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 16709836 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 15007068 | ||
| Pubmed | Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease. | 5.50e-05 | 4 | 106 | 2 | 28477215 | |
| Pubmed | Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML. | 5.50e-05 | 4 | 106 | 2 | 17662271 | |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 5.50e-05 | 4 | 106 | 2 | 23047493 | |
| Pubmed | SERPINA2 is a novel gene with a divergent function from SERPINA1. | 5.50e-05 | 4 | 106 | 2 | 23826168 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 12417285 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 18085638 | ||
| Interaction | TMEM100 interactions | 7.46e-07 | 35 | 99 | 5 | int:TMEM100 | |
| Interaction | BMP10 interactions | 1.34e-05 | 62 | 99 | 5 | int:BMP10 | |
| Cytoband | 16q23 | 7.87e-05 | 6 | 106 | 2 | 16q23 | |
| Cytoband | 22q11.23 | 2.58e-04 | 53 | 106 | 3 | 22q11.23 | |
| Cytoband | 14q24.3 | 1.33e-03 | 93 | 106 | 3 | 14q24.3 | |
| Cytoband | 11q25 | 1.66e-03 | 26 | 106 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 2.35e-03 | 31 | 106 | 2 | chr11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q23 | 2.51e-03 | 116 | 106 | 3 | chr16q23 | |
| Cytoband | 11q12.2 | 3.70e-03 | 39 | 106 | 2 | 11q12.2 | |
| GeneFamily | Acyl-CoA thioesterases | 5.99e-06 | 10 | 68 | 3 | 41 | |
| GeneFamily | Solute carriers | SLC25A34 SLC5A7 SLC13A3 SLC18B1 SLC6A9 SLC13A1 SLC7A10 SLC29A1 SLC22A31 | 1.63e-05 | 395 | 68 | 9 | 752 |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 4.93e-04 | 9 | 68 | 2 | 973 | |
| GeneFamily | C-type lectin domain family | 7.33e-04 | 47 | 68 | 3 | 494 | |
| GeneFamily | Aquaporins | 1.23e-03 | 14 | 68 | 2 | 305 | |
| GeneFamily | Carboxypeptidases | 2.79e-03 | 21 | 68 | 2 | 1321 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.17e-03 | 161 | 68 | 4 | 593 | |
| GeneFamily | Claudins | 3.35e-03 | 23 | 68 | 2 | 488 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 4.95e-03 | 28 | 68 | 2 | 745 | |
| GeneFamily | Serpin peptidase inhibitors | 8.53e-03 | 37 | 68 | 2 | 739 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | MAG ATP6V0B FA2H TSPAN19 SAMD12 SLC13A3 AQP6 TYRO3 SLC6A9 TECPR2 SCARB1 PCSK7 SMPD1 ADIPOR2 | 1.71e-06 | 754 | 104 | 14 | M39037 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | MAG SLC13A3 GPRC5C APOB CLDN7 AQP8 AQP6 EDN3 LHB SLC6A9 SERPINA1 SLC13A1 NCAN PCSK7 MMS19 PCSK4 NOS1 | 1.14e-05 | 1281 | 104 | 17 | M1884 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_500 | ANPEP AMACR SLC13A3 ACOT1 APOB CLDN7 AQP8 GLB1L2 ACOT4 SERPINA1 SLC13A1 ENTPD2 HDC | 4.07e-08 | 393 | 100 | 13 | gudmap_developingKidney_e15.5_early proxim tubul_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | ATP6V0B ANPEP AMACR SLC13A3 ACOT1 GPRC5C APOB CLDN7 AQP8 GLB1L2 ACOT4 SERPINA1 SLC13A1 ENTPD2 HDC | 3.86e-06 | 784 | 100 | 15 | gudmap_developingKidney_e15.5_early proxim tubul_1000 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-07 | 178 | 106 | 7 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-07 | 178 | 106 | 7 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-06 | 160 | 106 | 6 | 5d22c86deead516444349d495998e04586be4396 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Mast|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-06 | 160 | 106 | 6 | ca212634cf1875238071d1800ecdf34979a553fb | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-06 | 174 | 106 | 6 | e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-06 | 174 | 106 | 6 | ad5b56f0ace6455c033834b931ec870cc0dc9290 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 178 | 106 | 6 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 178 | 106 | 6 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-06 | 181 | 106 | 6 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 4.92e-06 | 182 | 106 | 6 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | (3)_Mast_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.24e-06 | 184 | 106 | 6 | dbfad62b925d835632b39a88ab95bd9af9cb7bee | |
| ToppCell | (3)_Mast_cell|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.24e-06 | 184 | 106 | 6 | 482907d3669597e25c8ff3e9a802a31415a0d654 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 186 | 106 | 6 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.11e-06 | 189 | 106 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | metastatic_Brain-MAST_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.30e-06 | 190 | 106 | 6 | 587bdf020ef222b5b76f0fae0cec3d44bcdac8e6 | |
| ToppCell | metastatic_Brain-MAST_cells-MAST|metastatic_Brain / Location, Cell class and cell subclass | 6.30e-06 | 190 | 106 | 6 | 9dc8afb99de9e4d41f26a41cd8cf1fc0100a54f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.89e-06 | 193 | 106 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-06 | 194 | 106 | 6 | 9d7f232ef5f27c28f325edfa6614f479013acbba | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | 2b724d2a36843801984d46a969d33149b76c9771 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.97e-06 | 198 | 106 | 6 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.97e-06 | 198 | 106 | 6 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.97e-06 | 198 | 106 | 6 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.44e-06 | 200 | 106 | 6 | a1503bcc774bed9563eda7cf90b8b5bf4405ad85 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.44e-06 | 200 | 106 | 6 | 25247f8b6ba6cd899ba6bd47e28e090d697e4632 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 129 | 106 | 5 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.59e-05 | 156 | 106 | 5 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.59e-05 | 156 | 106 | 5 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 3.93e-05 | 159 | 106 | 5 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.05e-05 | 160 | 106 | 5 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 160 | 106 | 5 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 162 | 106 | 5 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 163 | 106 | 5 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.56e-05 | 164 | 106 | 5 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.97e-05 | 167 | 106 | 5 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 167 | 106 | 5 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 173 | 106 | 5 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 173 | 106 | 5 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | Substantia_nigra-Macroglia|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.04e-05 | 174 | 106 | 5 | 7e7f7ca9a413ec255e54621800a279c771b9e6b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | ac3dc44755280e36c0947b6de3cd639dc17de8b6 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 178 | 106 | 5 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 178 | 106 | 5 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.72e-05 | 178 | 106 | 5 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 178 | 106 | 5 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.90e-05 | 179 | 106 | 5 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-05 | 179 | 106 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-05 | 180 | 106 | 5 | 8bd9e12589bff64987bac30af4d2514ba6f09300 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 181 | 106 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.47e-05 | 182 | 106 | 5 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Late_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 182 | 106 | 5 | f8257c884393f168f605d371e0840cfca8d3657e | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 7.66e-05 | 183 | 106 | 5 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-05 | 184 | 106 | 5 | 204d16c48f822c98dc4118ac97a4f99f7e1163c8 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 184 | 106 | 5 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.86e-05 | 184 | 106 | 5 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 3d7dd193a0826cc7a4e454a29236a16c315e5965 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-05 | 184 | 106 | 5 | 9365cdc52a2419e3f27e1c1c9310fa707d1e506b | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 45577ff91c3b2b303acd97239dde2463ea7a429c | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-05 | 184 | 106 | 5 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.86e-05 | 184 | 106 | 5 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 53b71c4ac86dc5e42763b8f64fbc917177531017 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 8.06e-05 | 185 | 106 | 5 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 8.06e-05 | 185 | 106 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-05 | 185 | 106 | 5 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-05 | 185 | 106 | 5 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-05 | 185 | 106 | 5 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-05 | 185 | 106 | 5 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.06e-05 | 185 | 106 | 5 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.27e-05 | 186 | 106 | 5 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 8.27e-05 | 186 | 106 | 5 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 187 | 106 | 5 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 187 | 106 | 5 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 187 | 106 | 5 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 187 | 106 | 5 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.48e-05 | 187 | 106 | 5 | 55d5b21517c89736592982af40fd4cd64be62a3c | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 188 | 106 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-05 | 188 | 106 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-05 | 188 | 106 | 5 | 3fe9d698ff8f540edebf8609e7d42d3f81271edb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 188 | 106 | 5 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.92e-05 | 189 | 106 | 5 | 96566f84c796d5b2e31f64090555f2b258f0c9f2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.92e-05 | 189 | 106 | 5 | b59cc66f7bb9b72895b775fbcf1ec1dc08610969 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-05 | 189 | 106 | 5 | 7bc6e152fb4fe5cd6db9407929c15843a5d8f8c4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.92e-05 | 189 | 106 | 5 | 1893765b1e3b306f1e133101c28403070a70c3c8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.92e-05 | 189 | 106 | 5 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.92e-05 | 189 | 106 | 5 | 19b639bc6b35fe1d1079f60c8138aa946a95f3bf | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.14e-05 | 190 | 106 | 5 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.14e-05 | 190 | 106 | 5 | b8c131020d20005cd9f23d26312196f62c958074 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.37e-05 | 191 | 106 | 5 | b5374674312ff5803a1d369f5533027532344679 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Micropapillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.59e-05 | 100 | 106 | 4 | 8743eadbe35a1fda5ca87d8901de35c573d268ef | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 9.60e-05 | 192 | 106 | 5 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| Drug | azide | 1.52e-06 | 180 | 102 | 8 | CID000033558 | |
| Drug | Leu-ala | 1.94e-06 | 46 | 102 | 5 | CID000081721 | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A | 2.87e-06 | 196 | 102 | 8 | 4075_UP | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.98e-06 | 197 | 102 | 8 | 3910_UP | |
| Drug | Alfadexum | 4.34e-06 | 54 | 102 | 5 | CID000024796 | |
| Drug | C8-ceramide | MAG FA2H APOB ABCA7 GLA GUSB CPT1C SCARB1 PCSK7 SMPD1 NOS1 PIK3R5 | 7.33e-06 | 556 | 102 | 12 | CID000002508 |
| Drug | dibutyryl cyclic 3',5'-AMP | MAG FA2H APOB AQP8 STING1 ABCA7 EDN3 LHB ADORA2A P2RY11 SCARB1 DNASE1L2 | 8.02e-06 | 561 | 102 | 12 | CID000002460 |
| Drug | Lopac-P-178 | 1.27e-05 | 67 | 102 | 5 | CID005478935 | |
| Drug | Sialic acids | 1.74e-05 | 329 | 102 | 9 | CID000349960 | |
| Drug | X l-1 | 1.80e-05 | 72 | 102 | 5 | CID000006343 | |
| Drug | AC1L2EXV | 1.86e-05 | 12 | 102 | 3 | CID000070823 | |
| Drug | AC1NAX4S | 1.99e-05 | 2 | 102 | 2 | CID004459028 | |
| Drug | pyridinyl imidazole | 2.00e-05 | 36 | 102 | 4 | CID000005171 | |
| Drug | naphthol-AS-D | 2.24e-05 | 37 | 102 | 4 | CID000067273 | |
| Drug | DL-arginine | 2.47e-05 | 344 | 102 | 9 | CID000000232 | |
| Drug | propionyl-L-carnitine | 2.49e-05 | 38 | 102 | 4 | CID000107738 | |
| Drug | sodium sulfate | 2.83e-05 | 79 | 102 | 5 | CID000024436 | |
| Drug | AC1Q6PMM | 3.07e-05 | 40 | 102 | 4 | CID000003211 | |
| Drug | mioflazine | 3.07e-05 | 14 | 102 | 3 | CID000072001 | |
| Drug | type-IV | 3.92e-05 | 281 | 102 | 8 | CID000000906 | |
| Drug | d Na | 4.69e-05 | 16 | 102 | 3 | CID000000671 | |
| Drug | malondialdehyde | 4.95e-05 | 213 | 102 | 7 | CID000010964 | |
| Drug | alaninamide | 5.67e-05 | 17 | 102 | 3 | CID000350287 | |
| Drug | poly(2-vinylpyridine | 5.67e-05 | 17 | 102 | 3 | CID000007521 | |
| Drug | ATEE | 5.84e-05 | 47 | 102 | 4 | CID000002004 | |
| Drug | ammonium sulfite | 5.94e-05 | 3 | 102 | 2 | CID000025041 | |
| Drug | mDIC | 5.94e-05 | 3 | 102 | 2 | CID000182560 | |
| Drug | PFPA | 6.78e-05 | 18 | 102 | 3 | CID000067742 | |
| Drug | Met-Ser | 6.78e-05 | 18 | 102 | 3 | CID004448381 | |
| Drug | Man(9)GlcNAc | 8.07e-05 | 51 | 102 | 4 | CID003081561 | |
| Drug | oxygen | 8.21e-05 | 499 | 102 | 10 | CID000000977 | |
| Drug | Avodart | 8.71e-05 | 52 | 102 | 4 | CID000152945 | |
| Drug | AC1N1QTU | 9.39e-05 | 53 | 102 | 4 | CID003985498 | |
| Drug | Inactin | 9.39e-05 | 53 | 102 | 4 | CID003032373 | |
| Drug | phosphocreatinine | 1.09e-04 | 21 | 102 | 3 | CID000071214 | |
| Drug | lithocholate-3-O-glucuronide | 1.19e-04 | 4 | 102 | 2 | CID000126511 | |
| Drug | sodium taurodihydrofusidate | 1.19e-04 | 4 | 102 | 2 | CID003035005 | |
| Drug | methyl myristate | 1.19e-04 | 4 | 102 | 2 | CID000031284 | |
| Drug | 8-SPT | 1.25e-04 | 57 | 102 | 4 | CID000001908 | |
| Drug | AC1NBU2J | 1.26e-04 | 22 | 102 | 3 | CID004473762 | |
| Disease | 39S ribosomal protein L33, mitochondrial measurement | 1.18e-05 | 2 | 102 | 2 | EFO_0801332 | |
| Disease | cardiovascular event measurement, response to placebo | 3.54e-05 | 3 | 102 | 2 | EFO_0006919, EFO_0008344 | |
| Disease | alpha globulin measurement, protein measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0004747, EFO_0004813 | |
| Disease | synaptosomal-associated protein 25 measurement | 1.18e-04 | 5 | 102 | 2 | EFO_0021858 | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 1.18e-04 | 5 | 102 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | neuropeptide W measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0801835 | |
| Disease | glucose intolerance (biomarker_via_orthology) | 1.76e-04 | 6 | 102 | 2 | DOID:10603 (biomarker_via_orthology) | |
| Disease | brain ischemia (implicated_via_orthology) | 2.42e-04 | 35 | 102 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | X-16935 measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0800763 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.86e-04 | 91 | 102 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | X-24747 measurement | 3.27e-04 | 8 | 102 | 2 | EFO_0022135 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 3.27e-04 | 8 | 102 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | response to darapladib, cardiovascular event measurement | 3.27e-04 | 8 | 102 | 2 | EFO_0006919, EFO_0008395 | |
| Disease | chymotrypsin-like elastase family member 2A measurement | 4.19e-04 | 9 | 102 | 2 | EFO_0802399 | |
| Disease | alpha-1-antitrypsin measurement | 4.19e-04 | 9 | 102 | 2 | EFO_0008327 | |
| Disease | X-17653 measurement | 4.19e-04 | 9 | 102 | 2 | EFO_0800783 | |
| Disease | mean corpuscular hemoglobin concentration | MAG RMI2 GPR152 LBR SERPINA2 ABCA7 SLC6A9 SCARB1 NCAN SLC7A10 SLC29A1 DNASE1L2 | 4.36e-04 | 1105 | 102 | 12 | EFO_0004528 |
| Disease | gallstones | 5.47e-04 | 108 | 102 | 4 | EFO_0004210 | |
| Disease | factor VIII measurement, coronary artery disease | 6.49e-04 | 113 | 102 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 7.64e-04 | 12 | 102 | 2 | EFO_0801493 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 9.00e-04 | 13 | 102 | 2 | C0369183 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 9.00e-04 | 13 | 102 | 2 | EFO_0800588 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 9.00e-04 | 13 | 102 | 2 | C1261502 | |
| Disease | osteoprotegerin measurement | 1.05e-03 | 14 | 102 | 2 | EFO_0005918 | |
| Disease | Spastic Paraplegia, Hereditary | 1.05e-03 | 14 | 102 | 2 | C0037773 | |
| Disease | phospholipids:total lipids ratio | 1.17e-03 | 227 | 102 | 5 | EFO_0020946 | |
| Disease | basophil measurement | 1.19e-03 | 60 | 102 | 3 | EFO_0803539 | |
| Disease | unipolar depression, autism spectrum disorder | 1.21e-03 | 15 | 102 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.99e-03 | 153 | 102 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | Amphetamine-Related Disorders | 2.26e-03 | 75 | 102 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 2.26e-03 | 75 | 102 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 2.26e-03 | 75 | 102 | 3 | C0236804 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 5 measurement | 2.38e-03 | 21 | 102 | 2 | EFO_0008115 | |
| Disease | autism spectrum disorder symptom | 2.86e-03 | 23 | 102 | 2 | EFO_0005426 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 3.11e-03 | 24 | 102 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.23e-03 | 85 | 102 | 3 | EFO_0004639, EFO_0004732 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFAGLEPMGLLWALE | 71 | Q86TX2 | |
| SLQWNMLRVLPAGLF | 271 | P22792 | |
| LSFAIGLTPMLGWNN | 131 | P29274 | |
| GLAGFLLLWSAVLIM | 116 | Q9NS82 | |
| GAPGLLWMGLVLALA | 26 | P17405 | |
| MPSSVSWGILLLAGL | 1 | P01009 | |
| LSLWEAPRGQNMLDG | 201 | Q9UHK6 | |
| LGGVASLLLSFVWMP | 11 | O60888 | |
| MWGLLLALAAFAPAV | 1 | Q96SM3 | |
| MNKGWLELESDPGLF | 1 | Q92560 | |
| SFAGLQPMGLLWALE | 71 | Q3I5F7 | |
| GWNDPDMLVIGNFGL | 261 | P06280 | |
| LPYWVSQLLGGMLGA | 111 | O94778 | |
| LPDFNAGAMENWGLV | 346 | P15144 | |
| WALMGFSLLLGNSIL | 156 | Q96Q80 | |
| LGTPYDLAIDMWSLG | 286 | Q9Y463 | |
| MGGLSPTLYWLGNFL | 1571 | Q8IZY2 | |
| MLGSLGLWALLPTAV | 1 | Q16671 | |
| PGESIWMALVLLGLF | 141 | Q16671 | |
| SGIALLIMGSFVPWL | 221 | Q86V24 | |
| PNYLGDLIMALAWSL | 546 | Q14739 | |
| SWPSLLGDMLADAIN | 86 | P19113 | |
| WLGVPALALFMSSLE | 291 | Q8N612 | |
| FLLLGIPGLESMHLW | 11 | Q8NGJ3 | |
| PAMLWGLSLFLNLPG | 11 | Q96HD1 | |
| KPWLSGFSVAMLGAL | 276 | Q96H96 | |
| AAGWVLAALLAMPTL | 151 | Q96G91 | |
| NDWDFPRNGLLMPLL | 191 | P43366 | |
| ALPLFWIMISASRGG | 6 | P20916 | |
| LGPSSGLLVDWLEML | 1611 | Q8N201 | |
| VALSWAASLGLALPM | 156 | O95665 | |
| ALGKMPDAVNFWLGE | 156 | P0C870 | |
| MILSLLFSLGGPLGW | 1 | Q9H8L6 | |
| AVEAAAPMGALWGLV | 6 | Q96T76 | |
| CSEMDLGGLPSWLLQ | 166 | Q8NCI6 | |
| LLLSMGGAWASREPL | 11 | P01229 | |
| LLPLLWAGALAMDPN | 6 | P20138 | |
| WALGYMLNLTNLIPA | 436 | Q9Y5L3 | |
| GMIALALEANPFLTW | 381 | Q6UW60 | |
| AGLFLLVPWVMGLAG | 26 | Q16549 | |
| MPALGPALLQALWAG | 1 | O43157 | |
| QLLGLLMLWVPGSSA | 6 | A0A0A0MRZ7 | |
| MLPWLLVFSALGIQA | 1 | Q96LB8 | |
| LLGLPANGLMAWLAG | 41 | Q8TDT2 | |
| QNLLEFMHVDLGLPW | 126 | Q15070 | |
| LPDGTGEFLDAWLML | 1191 | Q7Z6Z7 | |
| PMGDLGQLLFLEWDA | 96 | Q16795 | |
| MNLPTESGELWILGD | 351 | P0DJD8 | |
| SMAWLRDGQPLGLDA | 3466 | Q96RW7 | |
| WYGLPAVSNMLLEIG | 566 | P29475 | |
| VMLLLLGAFLGAWPA | 216 | Q9NQ84 | |
| QLAGAAWAAPFLAMV | 141 | Q8N148 | |
| PGLFMLGTFLWSLIE | 216 | Q7L5A8 | |
| GFAMASPNALVLWEA | 731 | Q02218 | |
| LAWFLQLDPSLGLME | 71 | Q8TCG5 | |
| MPFSVSWGVLLLAGL | 1 | P20848 | |
| GLLIFDASSSWGPQM | 1451 | P04114 | |
| QAGWLLISALMTLGP | 551 | Q86XA9 | |
| LMLNGWPVISAFAGD | 131 | P23435 | |
| MGGPRALLAALWALE | 1 | Q92874 | |
| GDGSRWNYALLVPML | 21 | Q96BQ5 | |
| MEPGLWLLFGLTVTS | 1 | P14138 | |
| FWVGPLMGALLASLI | 216 | Q13520 | |
| MARGSAVAWAALGPL | 1 | P08236 | |
| LMPLWNVLGFALGAG | 111 | Q99807 | |
| TLLGASLPAALGWMD | 11 | Q6MZW2 | |
| GLLMLGVTLPNSYWR | 16 | P56746 | |
| LILGLMTWAYAAGVP | 31 | Q92839 | |
| SEMDLGGLPSWLLQD | 141 | Q8IW92 | |
| VMLLGGWLLLAFNAI | 71 | Q6ICI0 | |
| QGLGALMSGLLLLFW | 246 | A6NKX4 | |
| MPWDIAILVGGGFAL | 431 | Q9BZW2 | |
| PWNIILLLGGGFAMA | 426 | Q8WWT9 | |
| MTNLALGRGAFLAWD | 276 | Q2VPK5 | |
| MNLPTESGELWILGD | 351 | P0DJD7 | |
| MSSGTELLWPGAALL | 1 | Q9GZY6 | |
| LDPSIMDFALQGNLW | 421 | Q96NZ1 | |
| AGLAGLRWSMGAFPL | 6 | Q75VX8 | |
| LDSFLLLMLGGIPWQ | 241 | Q9GZV3 | |
| PFTWMLALLGLSQAL | 116 | Q86WV6 | |
| AAAGRGPLDLAAVWM | 46 | Q96E14 | |
| LPEDSWLVALAGGMI | 201 | Q6PIV7 | |
| QGLWALISGLAMGLF | 411 | Q6NT16 | |
| GNMGPAAFWLLLFLL | 286 | Q16647 | |
| MGAPFVWALGLLMLQ | 1 | O14594 | |
| LPLLWFAESGAMEGE | 411 | Q8WTV0 | |
| LLTQGTLLLPDGWMD | 151 | Q8N8I0 | |
| WARGMPFSELAGLSG | 1176 | Q15477 | |
| SLGNEQWEFTLGMPL | 11 | Q9BSU1 | |
| MEGDGGTPWALALLR | 1 | P57078 | |
| LGLGTLLPWNFFMTA | 21 | Q99808 | |
| NWAEGMLADKIGIFP | 236 | Q7Z6J0 | |
| SFAGLEPMGLLWALE | 71 | Q8N9L9 | |
| LQLLGFSMALLGWVG | 6 | O95471 | |
| SLPGVNDFWLGINDM | 121 | O75596 | |
| FLGQLSMDLEGLEWL | 81 | Q96M19 | |
| VGWNMQLLPAGLASF | 106 | Q6UXF7 | |
| VGWNMQLLPAGLASF | 106 | Q8NCF0 | |
| LGMLDPWYERNVLGL | 611 | Q8WYR1 | |
| LMGAGLAVQGWFLLQ | 46 | O43557 | |
| FMGELWPLLLSAQEN | 101 | Q8IYB3 | |
| PFMWSNLGIGLAISL | 46 | Q99437 | |
| PGWAVAIGFLMALSS | 606 | P48067 | |
| AGLLKPDQFAESWMG | 791 | O15040 | |
| MLDGSPLARWLAAAF | 1 | O14904 | |
| LLFMGFGAWLLLDRN | 26 | P0C672 | |
| ASVAWMPGADGRALL | 241 | Q06418 | |
| PNWSALKYAGLQGLM | 926 | P35573 |